Jiangsu Hengrui Medicine
600276.SS
#484
Rank
ยฃ33.77 B
Marketcap
ยฃ5.29
Share price
-3.83%
Change (1 day)
0.69%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : ยฃ9.92 Million

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is ยฃ9.92 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31ยฃ0.16 B824.71%
2021-12-31ยฃ17.62 M
2015-12-31ยฃ1.04 M0.67%
2014-12-31ยฃ1.03 M-48.23%
2013-12-31ยฃ2 M101.9%
2012-12-31ยฃ0.99 M-51.53%
2011-12-31ยฃ2.04 M4.49%
2010-12-31ยฃ1.95 M116.57%
2009-12-31ยฃ0.9 M
2007-12-31ยฃ4.14 M31.9%
2006-12-31ยฃ3.13 M-9%
2005-12-31ยฃ3.44 M-44.7%
2004-12-31ยฃ6.23 M-75.73%
2003-12-31ยฃ25.7 M32.98%
2002-12-31ยฃ19.32 M-7.93%
2001-12-31ยฃ20.99 M41.95%
2000-12-31ยฃ14.78 M-3.64%
1999-12-31ยฃ15.34 M48.4%
1998-12-31ยฃ10.34 M8.9%
1997-12-31ยฃ9.49 M